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Abbreviations 
 AE, aqueous extract; AF, alkaloid fraction; Fr, fraction; ID50, dose of extract necessary to 
reduce the response by 50% relative to the control value; LD50, median lethal dose; NIH, 
National Institutes of Health; S.E.M, standard error of the means; v, volume; w, weight. 
 
Abstract 
Ethnopharmacological relevance: The leaves of Crassocephalum bauchiense have long been 
used in traditional Cameroonian medicine for the treatment of epilepsy, pain, inflammatory 
disorders, arthritis and intestinal pain. 
Aim of the study: In this study, we attempted to identify the possible antinociceptive action of 
the aqueous extract and the alkaloid fraction prepared from the leaves of Crassocephalum 
baucheiense. 
Materials and methods: Using acetic acid induced abdominal constrictions, formalin-, 
capsaisin- and glutamate-induced nociception, and hot plate assay procedures, the 
antinociceptive effects of the aqueous extract and the alkaloid fraction was assessed after oral 
administration in mice. Morphine sulphate was used as reference analgesic agent. Mice were 
submitted to the rota-rod task and open-field test in order to assess any non-specific muscle-
relaxant or sedative effects of the extracts of Crassocephalum bauchiense. Male and female 
Swiss mice were used to assess acute toxicity of these extracts.  
Results: The aqueous extract and the alkaloid fraction of Crassocephalum bauchiense 
produced a significant antinociceptive effects in the acetic acid, formalin, glutamate, capsaicin 
and hot plate tests. These antinociceptive effects of Crassocephalum bauchiense were 
significantly attenuated by pretreatment with naloxone. The extracts of Crassocephalum 
bauchiense did not alter the locomotion of animals in the open-field or rotarod tests, which 
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suggest a lack of a central depressant effect. The animals did not exhibit any acute toxicity to 
the aqueous extract and the alkaloid fraction, so it was not possible to calculate the LD50. 
Conclusion: The results confirm the popular use of Crassocephalum bauchiense as an 
antinociceptive, and contribute to the pharmacological knowledge of this species because it 
was shown that the aqueous extract and the alkaloid fraction of Crassocephalum bauchiense 
produced dose related antinociception in models of chemical and thermal nociception through 
mechanisms that involve an interaction with opioidergic pathway. 
 
Keywords: Crassocephalum bauchiense, aqueous extract, alkaloid fraction, antinociceptive 
action, opioidergic pathway. 
 
1. Introduction 
The genus Crassocephalum belongs to the very large and widely distributed Asteraceae 
family in the tribe Senicioneae. It has been reported that Crassocephalum genus consists of 
nearly 24 species (Wagner et al., 1999). Many of these species are used widely as food 
additives or in traditional medicine, prompting phytochemical investigations that have in turn 
uncovered a variety of alkaloids, diterpenes and coumarins (Asada et al., 1985; Kongsaeree et 
al., 2003; Mohamed-Elamir et al., 2008). Well accepted that many plant-derived compounds 
possess analgesic and anti-inflammatory properties. Recent studies have shown that the 
labdane diterpene of the air-dried parts of Crassocephalum mannii has anti-inflammatory 
activity through its cyclooxygenase inhibitory activity (Liua et al., 2006; Heras et al., 2007; 
Mohamed-Elamir et al., 2008). Although the potent activity of non-steroidal anti-
inflammatory drugs is noteworthy, they have also many severe adverse effects. The aim is 
therefore to identify medicinal plant agents with very little side effects as substitute 
therapeutics. 
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Crassocephalum bauchiense Huch (Asteraceae) is commonly used in traditional 
medicine in the north of Cameroon. The leaf extract has been used to treat several diseases, 
including epilepsy, pain, arthritis, intestinal pain and colics (Arbonnier, 2000). A decoction of 
the leaves has been reported to be useful in relieving bronchitis and the attendant fever. 
According to Cameroonian traditional healers, the plant is also effective in cases of cerebral 
deficit, behavioural disturbances in mentally-retarded children, inflammatory disorders and 
neuropathic pain. However, there is no detailed study on the alleged antinociceptives 
properties of this medicinal plant. To provide scientific evidence for its antinociceptive 
activities known in folk medicine, the main purpose of the present study was to evaluate the 
effects of the aqueous extract and the alkaloid fraction of Crassocephalum bauchiense leaves 
using different assays of the chemical nociception and the thermal model of nociception. 
 
2. Materials and methods 
2.1. Plant material 
Fresh leaves of Crassocephalum bauchiense used in this study were harvested in the Mawi 
area of Ngaoundéré, Cameroon in july 2007. Botanical identification was performed at the 
National Herbarium, Yaoundé, Cameroun. Voucher specimen No. 7954/SRF/Cam was 
deposited at the Yaoundé herbarium. 
 
2.2. Extraction and fractionation 
For the preparation of the aqueous extract of Crassocephalum bauchiense, 100 g of dried and 
powdered leaves was soaked in 1000 ml of distilled water for 72 h and filtered. The filtrate 
was then dried in the oven (Gallenhamp®, England) at 60°C to give an extract with a 7.5% 
yield (w/w). 
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The dried and powdered leaves of Crassocephalum bauchiense (1000 g) were 
extracted with acetone/H2O (7/3; 5 l) at room temperature. The combined extracts were 
evaporated in vacuo to afford a dark residue (652.45 g). The residue was suspended in warm 
water (1 l) and then extracted successively with ethyl acetate (0.5 l × 3) and n-butanol (0.5 l × 
3), and concentrated to give residue A (207.13 g) and B (385.51 g), respectively. The latter 
was resolved in warm water (1 l), acidified with 1 mol/l HCl to pH between 4 and 5, and 
extracted with CHCl3 (0.5 l × 3). The aqueous layer was neutralized with 1 mol/l NaOH to pH 
9 to 10 and extracted with CHCl3 (0.5 l × 3) once again and concentrated in vacuo to obtain 
the crude base (158.64 g; 41.15%). The crude base (158.64 g) was subjected to 
chromatography column on silica gel eluted using a gradient of CHCl3:CH3OH: 28% NH4OH 
(from 50:1:0.1 to 3:1:0.1, v/v) to afford twelve fractions: Fr. I (16.54 g; 10.42%), Fr. II (16.34 
g; 10.30%), Fr. III (12.68 g; 7.99%), Fr. IV (180.30 mg; 0.11%), Fr. V (2.44 g; 1.53%), Fr. VI 
(92.40 mg; 0.06%), Fr. VII (75.40 mg; 0.05%), Fr. VIII (41.27 mg; 0.03%), Fr. IX (39.20 mg; 
0.02%), Fr. X (4.23 g; 2.66%), Fr. XI (135.20 mg; 0.08%) and Fr. XII (63.50 mg; 0.04%). 
The fraction Fr. II (16.30 g) was chromatographed on silica-gel chromatography column 
using a gradient of petroleum ether:Me2CO:28%NH4OH (from 30:1:0.2 to 2:1:0.1, v/v) to 
give Fr. XIII (47.14 mg; 0.28%), Fr. XIV (32.75 mg; 0.02%), Fr. XV (21.63 mg; 0.01%), Fr. 
XVI (18.71 mg; 0.01%), Fr. XVII (32.13 mg; 0.02%) and Fr. XVIII (29.34 mg; 0.18%). The 
aqueous extract and the alkaloid fraction of Crassocephamum bauchiense were dissolved in 
saline 0.90% containing dimethyl sulfoxyde 2% (vehicle) and subjected to the following 
pharmacological studies. 
 
2. 3. Laboratory animals 
Swiss albino mice (20 - 25 g) of either sex were used in this study. All animals were housed 
in a controlled environment, with free access to food and water and were maintained on a 12 
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h/12 h day/night cycle. Each animal was used only once. The investigation conforms to the 
Guide for the Care and Use of Laboratory Animal published by the US National Institutes of 
Health (NIH No. 85 - 23, revised 1996). In all the experimental studies each group consisted 
of six to eight animals and received approval of the local ethical committee for animal 
handling and experimental procedure. 
 
2.4. Drugs and chemicals 
Acetic acid, dipyrone, formalin, glutamate, morphine sulphate were purchased from Sigma 
chemical Co. (St. Louis, MO, USA). Naloxone was obtained from Arkopharma (Carros, 
France). Dipyrone, glutamate and morphine were prepared in saline (0.90% NaCl) and 
contained 2% dimethyl sulfoxyde. In all the pharmacological test naloxone was administered 
15 min before the administration of the extracts of Crassocephalum bauchiense. Formalin 
stock solution was prepared in phosphate buffer solution (phosphate buffer solution 
concentration in mM: NaCl 137, KCl 2.70 and phosphate buffer, 10). Acetic acid was 
prepared in saline (0.90% NaCl). Capsaicin stock solution (10-2 M) was prepared by 
successively dissolving capsaicin in 10% ethanol, 10% tween 80 and 80% NaCl 0.90%. The 
stock solution was further diluted in saline upon administration to 80 mg/ml.  
 
2.5. Pharmacological analysis 
2.5.1. Abdominal constrictions induced by acetic acid 
The aqueous extract of Crassocephalum bauchiense (20, 40, 80 and 160 mg/kg, p.o.), the 
alkaloids fractions from Crassocephalum bauchiense (Fr. I, Fr. II, Fr. III, Fr. IV, Fr. V, Fr. VI, 
Fr. VII, Fr. VIII, Fr. IX, Fr. X, Fr. XI, Fr. XII, Fr. XII, Fr. XIV, Fr. XV, Fr. XVI, Fr. XVII  
and Fr. XVIII; 40 mg/kg, p.o.), the aqueous extract + naloxone (160 mg/kg, p.o. + 1 mg/kg, 
i.p.), the alkaloid fraction + naloxone (Fr. XVI, 40 mg/kg, p.o. + 1 mg/kg, i.p.),  morphine 
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sulphate (positive control, 5 mg/kg, s.c.) or vehicle (10 ml/kg, p.o.) were administered 1 h 
prior to acetic acid treatment. Acetic acid (0.60%, 10 ml/kg) was injected i.p. and the number 
of abdominal constrictions (writhings) during the following 30 min period was observed 
(Taïwe et al., 2011). A significant reduction in the number of abdominal constrictions by any 
treatment compared with vehicle treated animals was considered as an antinociceptive 
response. 
 
2.5.2. Formalin-induced nociception 
The formalin test was carried out as described by Tjolsen et al (1992). Mice were given the 
aqueous extract of Crassocephalum bauchiense (20, 40, 80 and 160 mg/kg, p.o.), the alkaloid 
fraction from Crassocephalum bauchiense (Fr. XVI; 5, 10, 20 and 40 mg/kg, p.o.), the 
aqueous extract + naloxone (160 mg/kg, p.o. + 1 mg/kg, i.p.), the alkaloid fraction + naloxone 
(Fr. XVI; 40 mg/kg, p.o. + 1 mg/kg, i.p.), morphine sulphate (positive control, 5 mg/kg, s.c.) 
or vehicle (10 ml/kg, p.o.) 1 h before injecting formalin. Pain was induced by injecting 
subcutaneously in the right hind paw 20 µl of 2.50% formalin (0.90% formaldehyde). The 
amount of time spent licking the injected paw was measured and considered as an indication 
of pain. The first phase of the nociceptive response normally peaks 0 – 5 min after injection 
and the second phase 15 – 30 min after formalin injection. These two phases correspond to 
the neurogenic and inflammatory pain responses, respectively (Hunskaar and Hole, 1987). 
 
2.5.3. Capsaicin-induced nociception 
The animals were individually placed in a transparent plexiglas observation chamber (15 × 15 
× 15 cm) for an adjustment period of 20 min. After this period, mice were given the aqueous 
extract of Crassocephalum bauchiense (20, 40, 80 and 160 mg/kg, p.o.), the alkaloid fraction 
from Crassocephalum bauchiense (Fr. XVI; 5, 10, 20 and 40 mg/kg, p.o.), the aqueous extract 
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+ naloxone (160 mg/kg, p.o. + 1 mg/kg, i.p.) and the alkaloid fraction + naloxone (Fr. XVI; 
40 mg/kg, p.o. + 1 mg/kg, i.p.). Control animals received vehicle (10 ml/kg, p.o.) or morphine 
sulphate (positive control, 5 mg/kg, s.c.). One h after these treatments, the right hind paw was 
injected with 20 µl of capsaicin (1.60 µg/paw). Nociception was assessed immediately after 
injection and quantified by paw licking time during a 5 min period (Santos and Calixto, 
1997). 
 
2.5.4. Glutamate-induced nociception 
Animals were treated with the aqueous extract of Crassocephalum bauchiense (20, 40, 80 and 
160 mg/kg; p.o.), the alkaloid fraction from Crassocephalum bauchiense (Fr. XVI; 5, 10, 20 
and 40 mg/kg; p.o.), the aqueous extract + naloxone (160 mg/kg, p.o. + 1 mg/kg, i.p.), the 
alkaloid fraction + naloxone (Fr. XVI; 40 mg/kg, p.o. + 1 mg/kg, i.p.) and dipyrone (positive 
control, 60 mg/kg, p.o.) or vehicle (10 ml/kg; p.o.) 1 h before test. A volume of 20 µl of 
glutamate (30 µmol/paw) was injected intraplantarly in the ventral surface of the right 
hindpaw. Animals were observed individually for 15 min following glutamate injection. The 
amount of time they spent licking the injected paw was recorded with a chronometer and was 
considered as indicative of nociception (Beirith et al. 2002). 
 
2.5.5. Hot plate test 
The method is an adaptation of that described by Eddy and Leimbach (1953). The hot plate 
was maintained at 55 ± 0.50°C. Animals were placed on the hot plate and the time between 
placement and licking of the hind paws or jumping was recorded as the index of response 
latency. The reaction time was recorded at 0, 30, 60, 120 and 180 min after administration of 
various doses of the aqueous extract of Crassocephalum bauchiense (20, 40, 80 and 160 
mg/kg; p.o.), the alkaloid fraction from Crassocephalum bauchiense (Fr. XVI; 5, 10, 20 and 
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40 mg/kg; p.o.), morphine sulphate (positive control, 5 mg/kg, s.c.), or vehicle (10 ml/kg, 
p.o.). A cut-off time of 30 sec was maintained to minimize tissue damage. 
 
2.6. Measurement of locomotor activity and motor performance 
The study of ambulatory behavior was carried out on mice according to a slightly modified 
method (Ngo Bum et al., 2009). The open field used was a wooden square box 40 × 40 × 45 
cm; the floor was divided into 16 smaller squares of equal dimensions (10 × 10 cm). During 
all the experiments, the laboratory room was dark. The mouse was placed individually into 
the centre of the arena and allowed to explore freely. The ambulations (the number of 
crossing sector lines with all four paws) were recorded, over 2 consecutive 30 min periods, 1 
h after administration of the aqueous extract of Crassocephalum bauchiense (20, 40, 80 and 
160 mg/kg; p.o.), the alkaloid fraction from Crassocephalum bauchiense (Fr. XVI, 5, 10, 20 
and 40 mg/kg; p.o.), morphine sulphate (5 mg/kg, s.c.), or vehicle (10 ml/kg, p.o.). 
The motor coordination test was performed to determine side effects of the 
Crassocephalum bauchiense extract using the rotating rod method (Duham and Miya, 1957). 
A preliminary selection of mice was made on the previous day of experiment excluding those 
that did not remain on the rotarod bar during a 1 min session each. The bar (diameter 2.50 cm) 
rotated at a constant speed of 12 revolutions per min. Selected animals were tested 1 h after 
administration of the aqueous extract of Crassocephalum bauchiense (20, 40, 80 and 160 
mg/kg; p.o.), the alkaloid fraction from Crassocephalum bauchiense (Fr. XVI, 5, 10, 20 and 
40 mg/kg; p.o.), morphine sulphate (5 mg/kg, s.c.), or vehicle (10 ml/kg, p.o.). The integrity 
of motor coordination was assessed on the basis of the number of falls from the rota-rod in 1 
min. During the test session itself, i.e. after oral treatment, both the latency to fall from the 
revolving bar and the number of falls were recorded. 
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2.7. Acute toxicity test 
The acute toxicity test for the aqueous extract and the alkaloid fraction of Crassocephalum 
bauchiense (Fr. XVI,) was carried out to evaluate any possible toxicity. Mice of either sex 
were divided into control and test groups. The first group served as a normal control treated 
with vehicle (10 ml/kg; saline 0.90% containing 2% DMSO, p.o.). The aqueous extract of 
Crassocephalum bauchiense (40, 80, 160, 320, 640, 1280, 2560 and 5120 mg/kg) and the 
alkaloid from Crassocephalum bauchiense (Fr. XVI, 40, 80, 160, 320, 1280, 2560 and 5120 
mg/kg) were administered orally to different groups of mice. After administration of these 
extracts, mice were allowed access to food and water ad libitum and behaviour parameters 
including convulsion, hyperactivity, sedation, grooming, loss of righting reflex, increased or 
decreased respiration, food and water intake and mortality were observed for a period of 14 
days. The median lethal dose (LD50) was estimated according to the method described by 
Litchfield and Wilcoxon (1949). 
 
2.8. Data analysis and statistics 
Data were expressed as mean ± standard error of the means (S.E.M.) per group. Statistical 
differences between control and treated groups were tested by two-way repeated measures 
analysis of variance (ANOVA), followed by Newman-Keuls post hoc test. The differences 
were considered significant at P<0.05. The ID50 (dose of extract necessary to reduce the 
response by 50% relative to the control value) and 95% confidence intervals values were 
determined by using linear regression. The statistical package used for the analysis was 
Graphpad Prism 5.01 for Window (Graphpad Prism Software, San Diego, CA, USA). 
 
3. Results 
3.1. Effects of Crassocephalum bauchiense on abdominal constriction induced by acetic acid 
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Oral administration of the aqueous extract of Crassocephalum bauchiense (80 and 160 
mg/kg) did not produce any irritation action “per se”, but caused a dose-related and 
significant inhibition [F(25, 97) = 109.58; p<0.001] of acetic acid-induced abdominal 
constriction in mice (Figure 1). The percentage of inhibition of constrictions was calculated as 
36.12% (80 mg/kg) and 57.81% (160 mg/kg). The calculated mean ID50 for oral 
administration of the aqueous extract of Crassocephalum bauchiense was 133.82 (112.86 – 
154.58) mg/kg. The alkaloids fractions from Crassocephalum bauchiense (Fr. II, Fr. VII, Fr. 
VIII and Fr. XVI) exhibited significant reduction [F(25, 97) = 173.19; p<0.001] in abdominal 
writhes induced by acetic acid compared to the control group. Such effects were observed in 
mice pre-treated by the narcotic analgesic, morphine sulphate (5 mg/kg) used as a reference 
drug. Naloxone antagonized antinociceptive effect of the extracts of Crassocephalum 
bauchiense in acetic acid-induced abdominal constriction in mice 
 
3.2. Effects of Crassocephalum bauchiense on the formalin test 
In vehicle treated control animals the mean paw licking response time was 65.81 ± 1.23 s in 
the early phase (0 to 5 min) and 71.58 ± 1.27 s in the late phase (15 to 30 min). Morphine 
sulphate treatment resulted in a marked reduction of response time to 24.35 ± 2.73 s and 23.82 
± 2.41 s in the early and late phases, respectively. The results of Table 1 show that the 
aqueous extract of Crassocephalum bauchiense (80 – 160 mg/kg) caused a significant dose-
related inhibition of the neurogenic (0 to 5 min) [F(11, 56) = 163.15; p<0.001] and the 
inflammatory (15 to 30 min) [F(11, 85) = 131.49; p<0.001] of the formalin-induced licking. 
The calculated mean ID50 value for these effects were 111.05 (98.54 – 148.21) and 114.25 
(99.73 – 157.87) mg/kg, and the maximal inhibitions were 61.03 and 54.84%, respectively. 
Pre-treatment of animals with the alkaloid fraction from Crassocephalum bauchiense has 
significant antinociceptive effects on both early (0 to 5 min) [F(11, 76) = 152.48; p<0.001] 
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and late phase (15 to 30 min) [F(11, 37) = 152.46; p<0.001] of formalin test as shown on 
Table 1. Its neurogenic-induced pain blockade, occurred at 40 mg/kg (60.20%), whereas 
beginning from 10 mg/kg (32.14%), the alkaloid fraction significantly blocked pain 
emanating from inflammation. The calculated mean ID50 values for these effects were 27.82 
(17.41 – 38.87) and 23.47 (19.21 – 36.23) mg/kg, against the early and the late phase of the 
formalin response, respectively. The maximal inhibitions of the early and the late phase were 
60.24 and 65.60%, respectively. Pre-treatment of mice with naloxone (1 mg/kg, i.p.), a non 
selective opioid receptor antagonist, completely and significantly reversed the antinociceptive 
effects of the extracts of Crassocephalum bauchiense in both phases of formalin test. 
 
3.3. Effects of Crassocephalum bauchiense on the capsaicin test 
The result of Figure 2 show that the aqueous extract of Crassocephalum bauchiense (20 – 160 
mg/kg) and the alkaloid fraction (5 – 40 mg/kg) given systematically produced dose-
dependant and equipotent inhibition of capsaicin-induced licking. The calculated mean ID50 
values and the maximal inhibition were 81.25 (68.14 – 98.41) and 13.66 (8.11 – 19.30) 
mg/kg, and 82.82 [F(6, 71) = 179.12; p<0.001] and 83.70% [F(6, 42) = 106.22; p<0.001], 
respectively. Morphine sulphate used as positive control, also reduced the licking behavior 
induced by capsaicin in mice, producing significant inhibition of 80.75% [F(6, 71) = 179.12; 
p<0.001]. Pretreatment of mice with naloxone (1 mg/kg; i.p.) 15 min before administration of 
the extracts of Crassocephalum bauchiense reversed the reduction in nociception inhibition. 
 
3.4. Effects of Crassocephalum bauchiense on the glutamate test 
Interestingly in the glutamate induced nociception in mice, the aqueous extract and the 
alkaloid fraction of Crassocephalum bauchiense, caused marked and the dose-related 
antinociception (Figure 3). The calculated mean ID50 values and the maximal inhibition were 
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95.62 (64.84 – 97.21) and 13.25 (8.32 – 18.70) mg/kg, and 72.45 [F(6, 35) = 134.51; 
p<0.001] and 76.01% [F(6, 42) = 115.17; p<0.001], respectively. Given orally dipyrone 
produced significant inhibition of 74.83% [F(6, 71) = 179.12; p<0.001] of the glutamate-
induced nociception in mice (Figure 3). Pre-treatment of mice with naloxone (1 mg/kg, p.o.), 
significantly prevented the antinociceptive effect induced by the oral administration the 
extracts of Crassocephalum bauchiense. 
 
3.5. Effects of Crassocephalum bauchiense on the hot plate test 
All the extracts of Crassocephalum bauchiense exhibited varying degree of antinociceptive 
activity in the thermal nociception model in mice. Figure 4 shows that the aqueous extract of 
Crassocephalum bauchiense tested marked increase [F(6, 79) = 115.25; p<0.001]  in the 
latency response in the hot plate algesiometer model of nociception, with the higher dose 
administered (160 mg/kg) and the maximal effect was observed in later times after oral 
administration (120 - 180 min). Besides, the best result was obtained with the alkaloid 
fraction from Crassocephalum bauchiense (40 mg/kg). In this regard, since 60 min after its 
oral administration it could be observed a significant increase [F(6, 35) = 134.51; p<0.0001]  
in baseline that reached maximal level (100% increase in baseline) at 180 min. Naloxone 
antagonized antinociceptive effect of the extracts of Crassocephalum bauchiense in hot plate 
assay procedures. 
 
3.6. Effects of Crassocephalum bauchiense on locomotor activity and motor performance 
Mice treated with the aqueous extract and the alkaloid fraction from Crassocephalum 
bauchiense, failed to display any detectable alteration in the locomotor activity, when 
compared to the cumulative value recorded from control vehicle-treated animals over 0 [F(9, 
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47) = 171.36; p>0.05], 30 [F(9, 47) = 171.36; p>0.07] and 60 [F(9, 47) = 171.36; p>0.06] 
minutes (Table 2). 
The aqueous extract and the alkaloid fraction of Crassocephalum bauchiense 1 h after 
oral administration did not significantly affect the motor response of the animals. The control 
response in the rotarod test was 58.24 ± 1.31 vs. 60 s in the presence of the aqueous extract 
[F(9, 47) = 171.36; p>0.06] and the alkaloid fraction of Crassocephalum bauchiense [F(9, 47) 
= 171.36; p>0.06], respectively. Likewise, as shown in Table 2, none of the aqueous extract 
[F(9, 82) = 193.41; p>0.07] or the alkaloid fraction of Crassocephalum bauchiense [F(9, 82) 
= 193.41; p>0.07], altered the number of falls from the revolving bar in the rotarod test. 
 
3.7. Acute toxicity test 
The aqueous extract (40 - 5120 mg/kg, p.o.) and the alkaloid fraction (40 - 5120 mg/kg, p.o.) 
prepared from the leaves of Crassocephalum bauchiense given to mice, had no effect on their 
behavioral and no mortality during the observation period of 14 days after administration, so 
it was not possible to calculate the LD50. Therefore, it can be indicated that the 
Crassocephalum bauchiense extracts has low toxicity profile. 
 
4- Discussion 
The result of the current study show that the aqueous extract and the alkaloid fraction 
prepared from the leaves of Crassocephalum bauchiense, produced dose-related and marked 
antinociceptive effect when assessed in different assays of the chemical nociception and the 
thermal model of nociception. In general, acetic acid-induced abdominal constriction is used 
to evaluate the compounds for peripheral antinociceptive activities (Gene et al., 1998; Le Bars 
et al., 2001; Sanchez-Mateo et al., 2006). Acetic acid injection produces peritoneal 
inflammation, which triggers a response characterized by writhing (Koster et al., 1959). 
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Related studies have demonstrated that acetic acid indirectly induces the release of 
endogenous mediators of pain (such as prostaglandins, kinins, histamin, etc.) that stimulate 
the nociceptive neurons, which are sensitive to non steroidal anti-inflammatory drugs and 
opioids (Derardt et al., 1980; Sanchez-Mateo et al., 2006). Our results indicated that the 
extracts of Crassocephalum bauchiense could reduce the number of writhings in animal 
models, implying that it had a powerful antinociceptive effect. However, the results of this 
writhing test alone were unable to ascertain whether the antinociception was central or 
peripheral effect. 
The advantage of the formalin model of nociception is that it can discriminate pain in 
its central and/or peripheral components. It has been reported that formalin-induced persistent 
pain in mice paws produced a distinct biphasic nociception (Hunskaar and Hole, 1987; 
Tjolsen et al., 1992). The nociceptive behavior after formalin injection was distinctly recorded 
in two phases. The first phase of paw licking/biting response starts immediately after injection 
and is considered probably due to direct stimulation of nociceptors (Dubuisson and Dennis, 
1977). The second phase which appears a little later is considered to be due to a combination 
of an inflammatory reaction in the peripheral tissue and changes in central processing 
(Tjolsen et al., 1992). Central analgesics, such as narcotics, inhibit both phases, while 
peripherally acting drugs, such as steroids (hydrocortisone, dexamethasone) and non-steroidal 
anti-inflammatory drugs suppress mainly the late phase (Hunskaar and Hole, 1987). A 
significant and dose related antinociceptive effect was clearly evident for all the tested 
extracts of Crassocephalum bauchiense against both neurogenic (early phase) and 
inflammatory (late phase) pain behavior caused by formalin injection in mice. 
In the present study, the possible involvement of the transient receptor potential 
vanilloid 1 receptor inhibition in the Crassocephalum bauchiense induced antinociception 
was investigated. Our findings showed that Crassocephalum bauchiense significantly 
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inhibited capsaicin-induced nociceptive behavior in a dose-dependent manner. Capsaicin, 
when injected into the mice paw, is capable of activating in a distinctive subpopulation of 
primary afferent fibers, which transmit the nociceptive information to central nervous system 
for the releasing of pro-inflammatory neuropeptides (Holzer, 1991). The intraplantar injection 
of capsaicin in mice hindpaw induced deep pain-like behaviour related to neurogenic pain, 
characterized by biting and licking the injected paw (Sakurada, 1992; Santos and Calixto, 
1997). Furthermore, the effect of capsaicin was antagonized with a transient receptor potential 
vanilloid 1 receptor antagonist (Calixto et al., 2005). It is known that there is a release of 
several chemical mediators, such as excitatory amino acid, substance P, kinins, calcitonin 
gene-related peptide, prostaglandin E2 and nitric oxide that contribute for the increase of pain 
process (Wu et al., 1998). Our results, allow us to suggest the influence of the 
Crassocephalum bauchiense extracts on the actions of neuropeptides.  
Currently, it is well-known that between different neurotransmitters that are involved 
on the pain models cited previously, the excitatory amino acids (glutamate and aspartate) 
presents a relevant role. It was reported that this nociceptive response caused by glutamate 
involves peripheral, spinal and supraspinal sites of action with glutamate receptors play an 
important role modulating this nociceptive response (Beirith et al., 2002). The data presented 
in our study showed that the Crassocephalum bauchiense was capable of interfering with the 
nociceptive response induced by glutamate, demonstrating, once more, the involvement of 
neurogenic pathways. Thus, such results suggest that the antinociception induced by 
Crassocephalum bauchiense is associated with its interaction with the glutamatergic system. 
To corroborate that the aqueous extract and the alkaloid fraction from the leaves of 
Crassocephalum bauchiense have antinociceptive activity, hot plate test was conducted. In 
the hot plate test, a central model that has a selectivity for opioid-derived analgesics (Abbott 
and Melzack, 1982), oral administration of the aqueous extract and the alkaloid fraction from 
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Crassocephalum bauchiense exerts a potent antinociceptive action confirming the central 
activity of this extract. 
The present results reveal that naloxone was able to significantly attenuate the 
antinociceptive activity of the investigated Crassocephalum bauchiense. This observation 
suggests a role for opioid mechanism in the antinociceptive action of the aqueous extract and 
the alkaloid fraction. However, other mechanisms responsible for the analgesic effect of 
Crassocephalum bauchiense have to be. 
The present study further demonstrates that, systemic administration of investigated 
Crassocephalum bauchiense did not produce any motor dysfunction, sedation or alteration in 
locomotor activity of animals. In the present study, we did not observe any mortality case up 
to the dose of 5120 mg/kg of the aqueous extract and the alkaloid fraction prepared from the 
leaves of Crassocephalum bauchiense. Therefore, we may suggest that the extract has no 
lethal toxicity in mice even in a dose of 5120 mg/kg they may be considered to be relatively 
safe.  
In conclusion, the present study demonstrated the central and peripheral 
antinociceptive activity of Crassocephalum bauchiense in the test models of chemical 
nociception induced by acetic acid, formalin, capsaicin and glutamate, as well as in the test 
model of nociception induced by thermal stimuli, and further suggested that antinociceptive 
activity of Crassocephalum bauchiense might be related to the involvement of the opioïdergic 
system, which merited further studies regarding the precise site and the mechanism of action. 
In further investigations, the different fractions of Crassocephalum bauchiense will be 
evaluated and the structural characterization of responsible components will be clarified. 
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Figure legends 
Figure 1. Influence of the oral treatment with the aqueous extract and the alkaloids fractions 
prepared from the leaves of Crassocephalum bauchiense or morphine sulphate on acetic acid-
induced writhing. Results are expressed as mean ± S.E.M., for 6 animals. The extracts at all 
doses used began manifesting its assuaging effect on the writing reflex 1 h following the 
administration. Data were analysis by two-way ANOVA, followed by Newman-Keuls post 
hoc test, ∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001, significantly different compared to the vehicle.  
 
Figure 2. Influence of the oral treatment with the leaves extracts of Crassocephalum 
bauchiense (panel A: aqueous extract, panel B: alkaloid fraction) or morphine sulphate on 
capsaicin-induced nociception. Results are expressed as mean ± S.E.M., for 6 animals. The 
amount of time spent licking and biting the injected paw was indicative of neurogenic pain 
and was recorded in 0 – 5 min. Data were analysis by two-way ANOVA, followed by 
Newman-Keuls post hoc test, ∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001, significantly different compared 
to the vehicle. 
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Figure 3. Influence of the oral treatment with the leaves extracts of Crassocephalum 
bauchiense (panel A: aqueous extract, panel B: alkaloid fraction) or dipyrone on glutamate-
induced nociception. Results are expressed as mean ± S.E.M., for 6 animals. The amount of 
time spent licking and biting the injected paw was indicative of neurogenic pain and was 
recorded in 0 – 15 min. Data were analysis by two-way ANOVA, followed by Newman-
Keuls post hoc test, ∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001, significantly different compared to the 
vehicle.  
 
Figure 4. Influence of the oral treatment with the leaves extracts of Crassocephalum 
bauchiense (panel A: aqueous extract, panel B: alkaloid fraction) or morphine sulphate on hot 
plate-induced nociception in mice. Results are expressed as mean ± S.E.M., for 6 animals. 
Data were analysis by two-way ANOVA, followed by Newman-Keuls post hoc test. aP<0.05, 
bP<0.01, cP<0.001, significantly different compared to the vehicle.  
Table 1: Influence of the oral treatment of the aqueous extract and the alkaloid fraction prepared from the leaves of Crassocephalum bauchiense 
on formalin-induced pain. 
Treatments Dose (mg/kg) Licking time (s) Inhibition (%) 
Early phase 
(0-5 min) 
Late phase 
(15-30 min) 
Early phase Late phase 
Vehicle – 65.81 ± 1.23 71.58 ± 1.23 – – 
AE 20 57.75 ± 3.22 56.73 ± 2.31 12.24 20.74 
AE 40 51.71 ± 2.37 42.34 ± 1.32* 21.42 40.84 
AE 80 29.82 ± 2.91** 34.81 ± 2.54*** 54.68 51.36 
AE 160 25.73 ± 1.24*** 32.33 ± 2.41*** 61.90 54.83 
AE + Naloxone 160 + 1 53.71 ± 4.15 63.82 ± 2.52 18.38 10.84 
      
AF 5 58.52 ± 3.54 56.24 ± 3.21* 10.78 21.43 
AF 10 44.73 ± 2.72* 46.22 ± 3.45** 32.03 35.42 
AF 20 32.51 ± 2.32** 32.31 ± 3.72*** 50.60 54.86 
AF 40 26.24 ± 3.14*** 24.72 ± 2.34*** 60.12 65.46 
AF + Naloxone 40 + 1 60.21± 5.23 67.75 ± 5.32 08.50 05.35 
Morphine 5 24.35± 2.73*** 23.82 ± 2.41*** 62.99 66.72 
 
Results are expressed as mean ± S.E.M., for 6 animals. The amount of time spent licking and biting the injected paw was indicative of pain and 
was recorded in 0 - 5 min (first phase) and 15 - 30 min (second phase). Data were analysis by two-way ANOVA, followed by Newman-Keuls 
post hoc test. ∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001, significantly different compared to the vehicle. 
 
 
Table 2: Influence of the oral treatment of the aqueous extract and the alkaloid fraction prepared from the leaves of Crassocephalum bauchiense 
on locomotor activity in the open field test and on motor performance in the rotarod test 
Treatments Dose (mg/kg) Locomotor activity 
 
 Motor coordination 
0 min 30 min 60 min 
 
Number of 
falls 
Time in the 
rotating bar (s) 
Vehicle – 18.45 ± 2.27 47.62 ± 8.61 74.82 ± 8.61  0.10 ± 0.10 58.24 ± 1.31 
AE 20 18.24 ± 3.52 39.28 ± 6.43 78.53 ± 9.41  0.10 ± 0.10 58.87 ± 1.73 
AE 40 17.86 ± 2.34 41.47 ± 7.59 79.63 ± 8.72  0.10 ± 0.00 59.70 ± 1.91 
AE 80 18.43 ± 3.62 44.48 ± 8.08 82.11 ± 9.21  0.00 ± 0.00 60.00 ± 0.00 
AE 160 18.62 ± 2.44 47.32 ± 9.21 81.82 ± 7.91  0.00 ± 0.00 60.00 ± 0.00 
        
AF 5 18.07 ± 2.32 41.94 ± 9.47 76.09 ± 4.08  0.10 ± 0.10 58.82 ± 5.11 
AF 10 17.86 ± 1.91 49.51 ± 8.22 81.58 ± 5.89  0.00 ± 0.00 60.00 ± 0.00 
AF 20 17.72 ± 1.68 51.53 ± 7.54 83.39 ± 4.67  0.00 ± 0.00 60.00 ± 0.00 
AF 40 18.22 ± 2.08 54.72 ± 6.48 86.47 ± 3.77  0.00 ± 0.00 60.00 ± 0.00 
Morphine 5 18.07 ± 1.86 31.63 ± 5.39* 44.29 ± 4.69**  0.80 ± 0.20** 36.93 ± 3.93* 
 
Results are expressed as mean ± S.E.M. of the number of crossing in a cumulative way or of the number of falls and the total time spent on 
therotating bar during a 1 min test, n = 6 animals. Data were analysis by two-way ANOVA, followed by Newman-Keuls post hoc test.∗P<0.05, 
∗∗P<0.01, significantly different compared to the vehicle. 
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